Sidoti Csr Predicts Hawkins’ FY2027 Earnings (NASDAQ:HWKN)

Hawkins, Inc. (NASDAQ:HWKN) – Sidoti Csr reduced their FY2027 earnings estimates for Hawkins in a research report issued to clients and investors on Tuesday, February 3rd. Sidoti Csr analyst D. Harriman now expects that the specialty chemicals company will earn $4.60 per share for the year, down from their previous forecast of $5.10. The consensus estimate for Hawkins’ current full-year earnings is $4.00 per share. Sidoti Csr also issued estimates for Hawkins’ Q3 2028 earnings at $1.01 EPS and FY2028 earnings at $5.10 EPS.

Other equities research analysts have also recently issued reports about the company. Zacks Research upgraded Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. BWS Financial reaffirmed a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a report on Thursday, January 29th. Finally, Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $162.50.

Hawkins Trading Up 0.5%

NASDAQ:HWKN opened at $129.97 on Thursday. Hawkins has a 12-month low of $98.30 and a 12-month high of $186.15. The firm has a market capitalization of $2.72 billion, a P/E ratio of 32.90, a P/E/G ratio of 2.73 and a beta of 0.86. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.35 and a quick ratio of 1.46. The business has a 50 day simple moving average of $144.45 and a 200 day simple moving average of $155.35.

Hawkins (NASDAQ:HWKN) last issued its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 EPS for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). The company had revenue of $244.08 million during the quarter, compared to analyst estimates of $252.51 million. Hawkins had a net margin of 7.75% and a return on equity of 16.85%.

Hawkins Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be issued a $0.19 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.76 annualized dividend and a yield of 0.6%. Hawkins’s dividend payout ratio is presently 19.24%.

Hedge Funds Weigh In On Hawkins

Large investors have recently bought and sold shares of the stock. AQR Capital Management LLC lifted its stake in shares of Hawkins by 9.0% in the 1st quarter. AQR Capital Management LLC now owns 12,331 shares of the specialty chemicals company’s stock worth $1,306,000 after acquiring an additional 1,017 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Hawkins by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,499 shares of the specialty chemicals company’s stock worth $1,218,000 after purchasing an additional 494 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Hawkins by 9.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 52,778 shares of the specialty chemicals company’s stock worth $5,590,000 after purchasing an additional 4,400 shares during the period. Jane Street Group LLC boosted its stake in Hawkins by 83.2% during the 1st quarter. Jane Street Group LLC now owns 38,416 shares of the specialty chemicals company’s stock valued at $4,069,000 after purchasing an additional 17,447 shares in the last quarter. Finally, Janney Montgomery Scott LLC bought a new position in Hawkins during the 2nd quarter valued at $250,000. Institutional investors and hedge funds own 69.71% of the company’s stock.

Hawkins News Summary

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Sidoti raised its long‑term outlook, forecasting FY2028 EPS of $5.10 (well above the current consensus of $4.00), indicating meaningful upside beyond the next 12–24 months. Sidoti Research Note
• Positive Sentiment: Sidoti published quarterly FY2028 estimates (Q1 2028 $1.52, Q2 2028 $1.43, Q3 2028 $1.01) which point to sequential recovery into 2028 and support the higher FY2028 target. Sidoti Research Note
• Neutral Sentiment: Sidoti provided a full set of quarterly and annual projections across FY2026–FY2028, giving investors updated modeling inputs and a clearer view of expected cadence. Use these to rework short‑term models and valuation sensitivity. Sidoti Research Note
• Negative Sentiment: Sidoti cut multiple near‑term estimates: FY2026 EPS lowered to $4.05 (from $4.30) and FY2027 EPS reduced to $4.60 (from $5.10), signaling weaker near‑term earnings than previously expected. Sidoti Research Note
• Negative Sentiment: Several 2026–2027 quarterly estimates were trimmed (Q4 2026 to $0.83; Q1–Q4 2027 quarters also lowered), which could pressure short‑term guidance and near‑term cash flow expectations. Sidoti Research Note

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.